Skip to Content

VY® Morgan Stanley Global Franchise S IVGTX

Medalist Rating as of | See Voya Investment Hub
  • NAV / 1-Day Return 16.83  /  +1.57 %
  • Total Assets 327.0 Mil
  • Adj. Expense Ratio
    1.200%
  • Expense Ratio 1.200%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Global Large-Stock Blend
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.46%
  • Turnover 14%

USD | NAV as of Feb 22, 2024 | 1-Day Return as of Feb 22, 2024, 11:13 PM GMT+0

Morningstar’s Analysis IVGTX

Will IVGTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin VY ® Morgan Stanley Global Franchise S's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IVGTX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 53.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

7.30 22.2 Mil
Technology

Philip Morris International Inc

6.53 19.9 Mil
Consumer Defensive

Accenture PLC Class A

5.92 18.0 Mil
Technology

Reckitt Benckiser Group PLC

5.54 16.8 Mil
Consumer Defensive

SAP SE

5.52 16.8 Mil
Technology

Visa Inc Class A

5.49 16.7 Mil
Financial Services

Danaher Corp

4.71 14.3 Mil
Healthcare

Thermo Fisher Scientific Inc

4.61 14.0 Mil
Healthcare

Intercontinental Exchange Inc

4.00 12.2 Mil
Financial Services

Becton Dickinson & Co

3.96 12.1 Mil
Healthcare